Bonus Biogroup

Bonus Biogroup is an advanced clinical-stage biotechnology company dedicated to developing "next-generation" therapies for a variety of indications in the field of regenerative medicine. Bonus BioGroup's mission is to develop and provide safe, effective, and affordable tissue engineering and cell therapy products to address severe diseases with limited treatment options. With deep expertise and advanced technology in the fields of tissue engineering and cell therapy, Bonus BioGroup is developing BonoFill (a personalized, autologous tissue-engineered living human bone graft) and MesenCure (an enhanced allogeneic cell therapy for treating inflammation and tissue damage). Both therapies have the potential to meet significant unmet clinical and market needs.